Nippon Life Insurance’s BioMarin Pharmaceuticals BMRN Stock Holding History

Nippon Life Insurance’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-11,828	Closed	-$1.07M	–	332
2017 Q2	$1.07M	Buy	11,828 +3,583	+43%	+$326K	0.02%	281
2017 Q1	$724K	Sell	8,245 -620	-7%	-$55.2K	0.01%	315
2016 Q4	$734K	Hold	8,865	–	–	0.01%	316
2016 Q3	$820K	Sell	8,865 -190	-2%	-$17.9K	0.02%	294
2016 Q2	$704K	Sell	9,055 -6	-0.1%	-$510	0.02%	296
2016 Q1	$747K	Sell	9,061 -2,331	-20%	-$190K	0.02%	289
2015 Q4	$1.19M	Buy	11,392 +1,393	+14%	+$145K	0.03%	254
2015 Q3	$1.05M	Sell	9,999 -2,320	-19%	-$310K	0.03%	269
2015 Q2	$1.69M	Sell	12,319 -96	-0.8%	-$11.9K	0.04%	223
2015 Q1	$1.55M	Buy	+12,415	New	+$1.32M	0.04%	239

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nippon Life Insurance's BMRN Position: Q3 2017 in Review

Nippon Life Insurance sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2017, closing a stake of 11,828 shares — an estimated $1.07M sold.

Nippon Life Insurance first reported a position in BMRN in Q1 2015 and held it in 10 quarters. The position peaked at $1.69M in Q2 2015. 411 funds tracked by Wall St. Rank hold BMRN as of Q3 2017.

Nippon Life Insurance reported no remaining BioMarin Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
Nippon Life Insurance sold 11,828 BioMarin Pharmaceuticals shares in Q3 2017, an estimated $1.07M.
Nippon Life Insurance first reported a position in BioMarin Pharmaceuticals in Q1 2015 and held it in 10 quarters.
Nippon Life Insurance's BioMarin Pharmaceuticals position peaked at $1.69M in Q2 2015.
411 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2017.

Based on Nippon Life Insurance's 13F filing for Q3 2017, filed 24 Oct 2017.